Crop Life Science Limited — Others, 14-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Crop Life Science Limited has announced a board meeting to review the Statement of Deviation(s) or Variation(s) concerning the utilisation of funds raised through its Initial Public Offer (IPO) for the half year ending September 30, 2024. No deviations or variations were reported in the allocation and utilisation of the ₹26.73 crore raised, according to subsequent audits. The financial health appears stable, with all funds being used as initially planned, bolstering investor confidence. Overall, this development reflects a disciplined approach in fund management, suggesting a positive outlook for stakeholders.